Quels marqueurs osseux chez les patients hémodialysés : phosphatases alcalines osseuses ou ß-CrossLaps ?
Guillaume Jean(NephroCare Tassin-Charcot), Charles Chazot(Clinique Charcot), Samuel Granjon(École d'Ingénieurs en Chimie et Sciences du Numérique), Patrik Deléaval(NephroCare Tassin-Charcot), Christie Lorriaux(Association pour l'Utilisation du Rein Artificiel), Brice Mayor(Association pour l'Utilisation du Rein Artificiel), Jean–Claude Souberbielle(Inserm), Jean‐Marc Hurot(NephroCare Tassin-Charcot)
Cited by 6
Related Papers
Survival as an index of adequacy of dialysis
|Kidney International|1992|769
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
|Nephrology Dialysis Transplantation|2010|478
Chronic Fluid Overload and Mortality in ESRD
|Journal of the American Society of Nephrology|2017|407
Vitamin D in Chronic Kidney Disease and Dialysis Patients
|Nutrients|2017|361
Importance of normohydration for the long-term survival of haemodialysis patients
|Nephrology Dialysis Transplantation|2012|225